Contribution of Malang quartzite-based silica in K2O/zeolite Y catalyst for methyl ester synthesis of off grade crude palm oil.

Malang quartzite contains a highly silica content. The silica changes the structural composition of Zeolite Y. Currently, a heterogeneous catalyst is developed to optimize transesterification of Off Grade CPO (Crude Palm Oil). The aims of this study are: (1) synthesize K2O/Zeolite Y using silica from Malang quartzite, (2) synthesize methyl esters from Off Grade CPO using K2O/Zeolite Y catalyst, and (3) to evaluate quartzite based-silica contribution in Zeolite Y for the reaction activity via GC-MS analysis. The experimental stages were: the oil preparation, esterification of the prepared oil, preparation of K2O/zeolite Y catalyst, and the transesterification. This study applied variations of [KOH] in Zeolite Y (10, 20, and 30 % w/w) and the concentration of the transesterification catalyst (2, 3, and 4 % w/w). The K2O/Zeolite Y catalyst was successfully synthesized by impregnation method. Methyl esters of Off Grade CPO resulted the highest yield of 95.05 % with 4 wt% of 30-K2O/Zeolite Y (30 % KOH impregnation). The synthesized methyl esters have a density of 0.877 g/mL, a viscosity of 4.6 cSt, a refractive index of 1.445 and an acid number of 0.384 mg/g according to the standard (SNI 7182:2015). The main components of the methyl ester based on GC-MS results were methyl octanoate, methyl decanoate, methyl dodecanoate, methyl 9-octadecanoate, methyl octadecanoate and methyl tetracosanoate. Using quartzite-based silica, a co-activity of the reaction has occurred.

In-silico, synthesis, structure elucidation and anticancer activity study of 2-(3,4-dichlorophenyl)-4H-benzo[d][1,3]oxazin-4-one.

The research aims to synthesize 2-(3,4-dichlorophenyl)-4H-benzo[d][1,3]oxazin-4-one and evaluate its anticancer activity against MCF-7. This compound was selected based on in-silico study conducted against several dihalophenylbenzoxazinone analogues using molecular docking towards Methionyl-tRNA synthetase. Synthesis of target compound was carried out using anthranilic acid and 3,4-dichlorobenzoyl chloride. The resulting compound was characterized using various spectroscopic analysis: 1D and 2D NMR, infrared and MS. In-silico studies was performed by MVD. Several designed compounds were docked into the active site on Methionyl-tRNA Synthetase (1PG2). Anticancer activity was evaluated by MTT Assay against MCF-7. 2-(3,4-dichlorophenyl)-4H-benzo[d][1,3]oxazin-4-one has been successfully synthesized with decent amount of yield 88%. Its spectroscopic analysis 1D and 2D NMR, MS, FTIR has proven the chemical structure of compound. In-silico studies toward the enzyme showed docking score of -76.04 Kcal/mol, higher than its native ligand (-93.50 Kcal/mol). Meanwhile, MTT assay result against MCF-7 showed IC50 value of 68.59ppm. Based on preliminary in-silico studies inhibited Methionyl-tRNA Synthetase, 2-(3,4-dichlorophenyl)-4H-benzo[d][1,3]oxazin-4-one was synthesized and tested in-vitro against MCF-7. Albeit the compound does not possess better docking score than native ligand, it is still argued that benzoxazine ring can be considered as a potential anticancer agent, as showed by MTT assay result which indicated moderate cytotoxicity.